Last update 08 May 2025
IDBiologics, Inc.

IDBiologics, Inc.

Startups
| Holding Company|2017|Tennessee, United States|
< 10
|
www.idbiologics.com

Overview

Tags

Infectious Diseases
Respiratory Diseases
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases3
Top 5 Drug TypeCount
Monoclonal antibody3
Top 5 TargetCount
SARS-CoV-2 S protein1
RSV F protein(Respiratory syncytial virus F protein)1

Related

4
Drugs associated with IDBiologics, Inc.
Cilgavimab
Target
SARS-CoV-2 S protein
Mechanism
SARS-CoV-2 S protein modulators
Active Org.
AstraZeneca PLCAstraZeneca PLC
Originator Org.
AstraZeneca UK Ltd.
Active Indication
COVID-19
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
RSV-199
Target-
Mechanism-
Active Org.
IDBiologics, Inc.IDBiologics, Inc.
Originator Org.
IDBiologics, Inc.IDBiologics, Inc.
Active Indication
Human Metapneumovirus Infection [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
IDB-003
Target
SARS-CoV-2 S protein
Mechanism
SARS-CoV-2 S protein inhibitors [+1]
Active Org.
IDBiologics, Inc.IDBiologics, Inc.
Originator Org.
Vanderbilt Vascular Biology Center
Active Indication
COVID-19
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with IDBiologics, Inc.
NCT06925919
/ RecruitingPhase 1
A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety Tolerability and Pharmacokinetics of IDB-011 (IDB-774+IDB-898) in Healthy Adults
100 Clinical Results associated with IDBiologics, Inc.
Login to view more data
0 Patents (Medical) associated with IDBiologics, Inc.
Login to view more data
100 Deals associated with IDBiologics, Inc.
Login to view more data
100 Translational Medicine associated with IDBiologics, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 31 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
2
Preclinical
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
RSV-199
Human Metapneumovirus Infection
More
Preclinical
IDB-003
 ( SARS-CoV-2 S protein )		COVID-19
More
Preclinical
IDB-002
 ( RSV F protein )		Respiratory Syncytial Virus Infections
More
Discovery
Cilgavimab
 ( SARS-CoV-2 S protein )		COVID-19
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free